Phase 1 safety and clinical activity of BLU-554 in advanced hepatocellular carcinoma (HCC)

Autor:	J.H. Park, Debashis Sarker, S.P. Choo, Vincenzo Mazzaferro, Y-K Kang, Max Sung, Richard D. Kim, Antoine Hollebecque, Tim Meyer, C. Clifford, Sandrine Faivre, Thomas Yau, Beni B. Wolf, J. Whisenant, Andrew X. Zhu, J.S. Yoon, Teresa Macarulla, O. Schmidt-Kittler, Hongliang Shi, Ho Yeong Lim
Rok vydání:	2017
Předmět:	0301 basic medicine 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology business.industry 030220 oncology & carcinogenesis Hepatocellular carcinoma medicine Cancer research Hematology medicine.disease business
Zdroj:	Annals of Oncology. 28:v122
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx367
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::982f6e1fb9acda3d03a36992390ca957 https://doi.org/10.1093/annonc/mdx367 Zobrazit plný text záznamu